Showing results (361-370 of 409) with videos related to
Sort By:
Pageof 41
Kidney International|June 17, 2018
Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcomeFranz Schaefer, Gianluigi Ardissino, Gema Ariceta, et al.Blood|March 9, 2022
Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosisBrian Craven, William Lester, Sara Boyce, et al.Blood|December 24, 2015
Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy useIda Martinelli, Anthonie W A Lensing, Saskia Middeldorp, et al.Hemasphere|September 15, 2021
The EHA Research Roadmap: Blood Coagulation and Hemostatic DisordersSabine Eichinger, Pierre E Morange, Marco Cattaneo, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2007
High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humansRakesh S Birjmohun, Sander I van Leuven, Johannes H M Levels, et al.Blood|November 2, 2022
Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapyAndrew J Doyle, Matthew J Stubbs, Tina Dutt, et al.The Journal of Infectious Diseases|January 1, 2003
Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humansAnnelies Verbon, Joost C M Meijers, C Arnold Spek, et al.The New England Journal of Medicine|September 3, 2020
Antisense Inhibition of Prekallikrein to Control Hereditary AngioedemaDanny M Cohn, Nicholas J Viney, Lauré M Fijen, et al.Journal of Thrombosis and Haemostasis : JTH|September 22, 2022
Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES studyMarie Scully, Javier de la Rubia, Katerina Pavenski, et al.Physiological Reports|February 12, 2024
Mechanisms underlying exercise intolerance in long COVID: An accumulation of multisystem dysfunctionAlexandra Jamieson, Lamia Al Saikhan, Lamis Alghamdi, et al.Pageof 41